ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation To CTL019 in ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 24 | June 11, 2014

Download PDF Visit The Full Archive

Related Articles

HOP Development Proceeding Guidelines For New, Revision Of Existing Control Grants Being Written

July 24, 1981

Professional Societies: AACR To Establish A Foundation To fund Outreach, Education

April 23, 1999

DCT Advisors Okay PA In Imaging Patters Of Care RFA; Contracts

March 5, 1993

Estrogen-Only HRT Little Risk In Endometrial Cancer, GOG Study Indicates

March 26, 2004

In Brief: Michael Friedman to Retire as CEO of City of Hope

March 1, 2013

Chabner Object To Yarbro’s Remarks On Federal Role In Clinical Research

April 15, 1983